Grant Izmirlian, Lev A Sirota, Vance W Berger, Victor Kipnis
{"title":"The fundamentals of multiplicity adjustment in biostatistics.","authors":"Grant Izmirlian, Lev A Sirota, Vance W Berger, Victor Kipnis","doi":"10.1093/jncimonographs/lgae050","DOIUrl":null,"url":null,"abstract":"<p><p>The statistical problem of multiplicity is concerned with making protected multiple inferences and their valid interpretation in a particular study. Most discussions of multiplicity focus on the increase of type I error rate if testing is done without any adjustment, with only a few papers discussing its ramifications for type II errors/power. We provide a survey of main approaches to protected inference in biomedical studies, touching on procedures to control the family-wise error rate, false discovery rate, as well as false discovery exceedance probability. We discuss several notions of power including total power, average power, and power defined as exceedance probability for the true positive proportion. We provide commentary on best practices for adjusting for multiplicity in both type I and type II errors within families defined by primary, secondary, and exploratory endpoints in clinical trials and in experimental studies.</p>","PeriodicalId":73988,"journal":{"name":"Journal of the National Cancer Institute. Monographs","volume":"2025 68","pages":"10-13"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11848033/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute. Monographs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncimonographs/lgae050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The statistical problem of multiplicity is concerned with making protected multiple inferences and their valid interpretation in a particular study. Most discussions of multiplicity focus on the increase of type I error rate if testing is done without any adjustment, with only a few papers discussing its ramifications for type II errors/power. We provide a survey of main approaches to protected inference in biomedical studies, touching on procedures to control the family-wise error rate, false discovery rate, as well as false discovery exceedance probability. We discuss several notions of power including total power, average power, and power defined as exceedance probability for the true positive proportion. We provide commentary on best practices for adjusting for multiplicity in both type I and type II errors within families defined by primary, secondary, and exploratory endpoints in clinical trials and in experimental studies.
多重性统计问题涉及在特定研究中进行受保护的多重推论及其有效解释。关于多重性的讨论大多集中在不做任何调整的情况下进行测试时 I 型误差率的增加,只有少数论文讨论了其对 II 型误差/功率的影响。我们对生物医学研究中保护推断的主要方法进行了调查,涉及控制族内误差率、错误发现率以及错误发现超概率的程序。我们讨论了几种功率概念,包括总功率、平均功率和定义为真阳性比例超概率的功率。我们对临床试验和实验研究中根据主要、次要和探索性终点定义的族内 I 型和 II 型误差调整多重性的最佳实践进行了评述。